4Panesar SS, Javad S, De Silva D, et al. Tile epidemiology of anaphylaxis in Europe: a systematic review[J]. Allerg 2013, 68: 1353-1361.
5Worm M, Edenharter G, RueffE et al. Symptom profile and risk factors of anaphylaxis in Central Europe[J]. Allergy, 2012, 67: 691-698.
6Sala-Cunill A, Cardona V, Labrador-HorrilloM, ,et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients [J]. Int Arch Allergy Immunol, 2013,160:192-199.
7Hompes S, Kohli A, Nemat K, et al. Provoking allergens and treatment of anaphylaxis in children and adolescents-data from the anaphylaxis registry of German-speaking countries[J]. Pediatr Allergy Immunol, 2011, 22: 568-S74.
8Nurmatov UB, Rhatigan E, Simons FER, et al. H2 antihistamines for the treatment of anaphylaxis with and without shock: a systematic review[ J]. Ann Allergy Asthma Immunol, 2014, 112:126-131.
9Rueff F, Bilo MB, Cichocka-Jarosz E, et al. Immunotherapy for Hymenoptera venom allergy: too expensive for European health care? [J]. Allergy, 2013, 68: 407-408.
10Mosbech H, Muller U, Behalf of the Study Group. Side-effects of insect venom immunotherapy: results from an EAACI multicenter study[J]. A11erg 2000, 55: 1005-1010.
